Novan Announces Corporate Update Conference Call and Webcast
July 25, 2017 16:05 ET
|
Novan, Inc.
MORRISVILLE, N.C., July 25, 2017 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced that the Company will host a conference call on Wednesday, Aug. 2, at 8:30...
Novan to Present Safety and Efficacy Data for SB204 Program in Adolescents at 13th World Congress of Pediatric Dermatology
July 07, 2017 09:05 ET
|
Novan, Inc.
MORRISVILLE, N.C., July 07, 2017 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced that pharmacokinetic, safety and efficacy data for SB204, an investigational...
Novan Announces Leadership Adjustments and Business Update
June 05, 2017 08:30 ET
|
Novan, Inc.
Aligns existing talent and experience with next phaseAccelerates broadening the application of the scienceIntends regulatory follow up with regard to SB204 for acneResource alignment to near term...
Novan Reports First Quarter 2017 Financial Results
May 12, 2017 09:05 ET
|
Novan, Inc.
MORRISVILLE, N.C., May 12, 2017 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced the Company’s financial results for the first quarter of 2017. Total...
Novan Presents Safety Data for SB204 Program
April 27, 2017 09:13 ET
|
Novan, Inc.
MORRISVILLE, N.C., April 27, 2017 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced that pharmacokinetic data for SB204, a once-daily, topical monotherapy for...
Novan Presents Preclinical Data from Inflammatory Skin Diseases Program
April 27, 2017 09:05 ET
|
Novan, Inc.
MORRISVILLE, N.C., April 27, 2017 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced that data from two preclinical studies with SB414, a nitric oxide-releasing...
Novan Reports Positive Topline Results with SB208 in Phase 2 Trial
April 12, 2017 06:06 ET
|
Novan, Inc.
MORRISVILLE, N.C., April 12, 2017 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced positive topline results from the Company’s Phase 2 clinical trial with...
Novan Welcomes Key Opinion Leaders to New Advisory Council
April 04, 2017 09:05 ET
|
Novan, Inc.
MORRISVILLE, N.C., April 04, 2017 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced that the Company has formed an Advisory Council comprised of key opinion...
Novan Reshapes Executive Management Team
March 22, 2017 09:20 ET
|
Novan, Inc.
Former Quintiles Executive Paula Brown Stafford Joins Novan as Chief Development Officer Stanley Hollenbach Promoted to Senior Vice President of Research and Development William L. Hodges Appointed...
Novan Reports Fourth Quarter and Full Year 2016 Financial Results
March 20, 2017 08:05 ET
|
Novan, Inc.
MORRISVILLE, N.C., March 20, 2017 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced the Company’s financial results for the fourth quarter and full year 2016....